Trial intelligence / Profile preview

Transdermal Estradiol in Hormone Refractory Prostate Cancer

NCT00176644Phase 2Terminated

Sponsor
University of Medicine and Dentistry of New Jersey
Start
May 2005
Primary completion
Dec 2008
Countries
1
01

Overview

A Phase 2 trial of estradiol topical in prostate cancer (PCa), sponsored by University of Medicine and Dentistry of New Jersey. Started May 2005; status: terminated.

02

Drugs

estradiol topical
03

Conditions

prostate cancer (PCa)

Beyond the preview

Go deeper on NCT00176644.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00176644.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call